HKU Scholars Hub: Browsing DSpace

Browsing by Author Yeo, W

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 15 to 33 of 33 < previous

	Title	Author(s)	Issue Date	Views
	Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study Journal:Journal of Hepatology	Yau, TCC Hsu, C Kim, TY Choo, S Kang, YK Hou, MM Numata, K Yeo, W Chopra, A Ikeda, M Kuromatsu, R Moriguchi, M	2019	272
	Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Journal:Lancet	El-Khoueiry, AB Sangro, B Yau, TCC Crocenzi, TS Kudo, M Hsu, C Kim, TY Choo, SP Trojan, J Welling, TH Meyer, T Kang, YK Yeo, W Chopra, A Anderson, J Dela Cruz, C Lang, L Neely, J Tang, H Dastani, HB Melero, I	2017	151
	Patterns of psychological distress among Chinese women diagnosed with advanced breast cancer Proceeding/Conference:IPOS / COSA 2012	Lam, WWT Ng, J Tsang, J Yau, TK Soong, I Yeo, W Suen, J Ho, WM Wong, KY Kwong, A Suen, D Sze, WK Ng, A Fielding, R	2012	71
	Pembrolizumab in patients with advanced/metastatic acral lentiginous melanoma Proceeding/Conference:Annals of Oncology	Loong, H Yuen, C Mo, F Chan, TC Lee, KWC Chan, ACY Wong, ACY Wong, KCW Lam, CM Tong, J Wong, CKH Yeo, W	2017	65
	Phase 1/2 Safety and Antitumor Activity of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Interim Analysis of the CheckMate 040 Dose-Escalation Study Proceeding/Conference:Liver Cancer	El-Khoueiry, AB Sangro, B Yau, TCC Crocenzi, TS Welling, TH, III Yeo, W Chopra, A Anderson, J dela Cruz, C Lang, L Neely, J Melero, I	2016	64
	Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research	Lim, HY Merle, P Weiss, KH Yau, TCC Ross, P Mazzaferro, V Blanc, JF Ma, YT Yen, CJ Kocsis, J Choo, SP Sukeepaisarnjaroen, W Gérolami, R Dufour, JF Gane, EJ Ryoo, BY Peck-Radosavljevic, M Dao, T Yeo, W Lamlertthon, W Thongsawat, S Teufel, M Roth, K Reis, D Childs, BH Krissel, H Llovet, JM	2018	50
	Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma Journal:Cancer Chemotherapy and Pharmacology	Chan, SL Wong, C-H Lau, CPY Zhou, Q Hui, CWC Lui, VWY Ma, BBY Chan, ATC Yeo, W	2013	52
	Prevalence of psychosocial unmet needs of Chinese women facing advanced breast cancer Proceeding/Conference:Meeting of East Asia Psycho-Oncology Society, EAPOS 2010	Au, AHY Lam, WWT Kwong, A Suen, DTK Tsang, JWH Yeo, W Suen, J Ho, WM Yau, TK Soong, I Wong, KY Sze, WK Ng, A Girgis, A Fielding, R	2010	97
	Profile of mood states and quality of life of Chinese postmastectomy women in Hong Kong: Integrating variable- and person-centered approaches Journal:Health Care for Women International	Shin, K Ganotice, FA Downing, K Yip, LW Han, F Yeo, W Suen, JJS Lee, KM Ho, SSM Soong, SI Wong, KY Kwok, CCH Leung, K	2016	122
	Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer Journal:Psycho-Oncology	Au, A Lam, W Tsang, J Yau, TK Soong, I Yeo, W Suen, J Ho, WM Wong, KY Kwong, A Suen, D Sze, WK Ng, A Girgis, A Fielding, R	2013	73
	Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma Journal:Biochemical Pharmacology	Zhou, Q Lui, VWY Lau, CPY Cheng, SH Ng, MHL Cai, Y Chan, SL Yeo, W	2012	38
	Symptom clustering in different groups of cancer survivors Proceeding/Conference:Meeting of East Asia Psycho-Oncology Network, EAPON 2012	Ye, M Lam, WWT Tsang, JWH Lee, VHF Soong, I Chan, KKL Lee, C Sze, WK Yeo, W Suen, J Ho, WM Fielding, R	2012	25
	Symptom clusters in cancer survivors in Hong Kong - a cluster analysis Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012	Ye, M Lam, WWT Tsang, J Lee, VHF Soong, I Chan, KKL Lee, C Sze, WK Ng, A Yeo, W Suen, J Ho, WM Fielding, R	2012	30
	Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma Journal:Future Oncology	Zhou, Q Lui, VWY Yeo, W	2011	50
	The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines Journal:Investigational New Drugs	Ma, BBY Sung, F Tao, Q Poon, FF Lui, VW Yeo, W Chan, SL Chan, ATC	2010	42
	Trajectory patterns of supportive care needs among Chinese women with advanced breast cancer Proceeding/Conference:Psycho-Oncology	Lam, WWT Tsang, JWH Yeo, W Suen, J Ho, WM Yau, TK Soong, I Wong, KY Kwong, A Suen, TKD Sze, WK Ng, A Girgis, A Fielding, R	2014	56
	Unmet supportive care needs in Hong Kong Chinese women confronting advanced breast cancer Proceeding/Conference:Psycho-Oncology	Au, A Lam, WWT Cheung, O Tsang, J Yau, TK Soong, I Yeo, W Suen, J Ho, WM Wong, KY Kwong, A Suen, DTK Sze, WK Ng, A Girgis, A Fielding, R	2011	134
	Validation of the Chinese version of the Short-form Supportive Care Needs Survey Questionnaire (SCNS-SF34-C) Journal:Psycho-Oncology	Au, A Lam, WWT Kwong, A Suen, D Tsang, J Yeo, W Suen, J Ho, WM Yau, TK Soong, I Wong, KY Sze, WK Ng, A Girgis, A Fielding, R	2011	266
	Validation of the supportive care needs survey (SCNS-SF34): the Chinese version (Ch-SCNS-SF34) Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2010	Au, AHY Lam, WWT Kwong, A Suen, D Tsang, J Yeo, W Suen, J Ho, WM Yau, TK Soong, I Wong, KY Sze, WK Ng, A Girgis, A Fielding, R	2010	187

Showing results 15 to 33 of 33 < previous